We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Project Orbis is a programme to review and approve promising cancer drugs helping patients access treatments faster.
How to use a patient-reported outcomes and experiences study to evaluate your digital health product.
This national approval was granted after an Access Consortium new active substance work-sharing initiative (NASWSI) procedure.
As with all products, the MHRA will keep its safety under close review.
Summary of the latest safety advice for medicines and medical device users
Semaglutide is the first weight loss drug approved in the UK as a preventative treatment for those with established cardiovascular disease
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).